A stern warning, without mincing words, was delivered yesterday to European Commission President Ursula von der Leyen by some of the main trade associations in the pharmaceutical sector during a meeting held amidst the tariff turmoil triggered by US President Donald Trump. Although the sector has not yet been included in the list of products for which tariffs have increased, the danger is more than real, with Trump himself warning that he will soon impose "significant tariffs on pharmaceutical imports".
Such a decision could mark a point of no return for many European companies for whom relocation to the USA could become almost inevitable.
Already, “the United States surpasses Europe on every metric for investors, from capital availability to intellectual property, from approval speed to returns on innovation.
